Acarix raises EUR 3.6 million

Acarix raises EUR 3.6 million

Danish Acarix has raised EUR 3.6 million, to be used for market saturation and promotion of their ground breaking technology, the CADScor System.

Acarix has developed the CadScor System fior early diagnosis of Coronary Artery Disease (CAD). 

Read more

 

Fund SEED Capital Fund II
Portfolio Company Acarix
Date of Transaction 06.03.2013
Transaction Finance Round
Finance Round Size (EUR) 3.6m
Company Sector Health Care & Life Science
Company HQ Denmark
Company Stage Seed
19.12.2016

FSN Capital closes new fund

FSN Capital Partners, a pan-Nordic mid-market private equity advisor, has announced the final closing of FSN Capital V at a hard cap of SEK 9.62 billion, exceeding the SEK 8.5 billion target. FSN Capita...

Read the full story
19.12.2016

EQT VI to sell BSN medical to SCA

EQT VI has entered into an agreement to sell BSN Medical to Svenska Cellulosa Aktiebolaget (“SCA”) in a transaction valuing BSN at EUR 2 740 million. EQT VI acquired BSN in August 2012 and the growth...

Read the full story

Recent News

Read all news

Private Equity Research

Get in touch with us

Call (+47) 55 54 70 00.

Follow us on the social networks

LinkedIn, Twitter and RSS
LinkedIn Twitter RSS

For press inquiries

Ingibjörg Meyer-Myklestad
imm(at)argentum.no

Tel: (+47) 55 54 70 00
Mob: (+47) 906 05 505

Postal Address

Postboks 3964 – Sandviken
5835 Bergen

Postboks 1997 Vika,
0125 Oslo

Bergen Office

Bradbenken 1, 5003 Bergen
Tel: (+47) 55 54 70 00


Oslo Office

Kronprinsesse Märthas Plass 1
0160 Oslo